1. Introduction
Activated natural killer cell immunotherapy (ANK therapy) is a treatment in which NK cells are extracted from the patient’s own blood, expanded, activated, and then returned to the body.

1. Abstract
Stop NOx elimination by ammonia. Stop water clean centre. Abandon bonfire inhibition rule. These 3 items are essential to promote CO2 assimilation to stop global warming stop.

1. Abstract
Familial partial lipodystrophy (FPLD) is a heterogeneous group of rare genetic disorders (estimated prevalence <1/100,000) characterized by a lipodystrophy phenotype combined with metabolic abnormalities such as insulin resistance and hypertriglyceridemia. Several subtypes have been described

1. Abstract
Hypertrophic obstructive cardiomyopathy (HOCM) is a genetically driven cardiac condition most often involving asymmetric septal hypertrophy. Mid-ventricular and apical variants are rare, accounting for less than 5% of cases in Western populations, and present unique diagnostic and prognostic challenges.

1. Abstract
It is said that lifestyle-related diseases and deterioration of beauty caused by aging are caused by active oxygen. In particular, aging was coded in ICD-11, so it was positioned as a disease. In light of this, it can be seen that aging is reversible.

1. Abstract
A 34-year-old male patient with opioid use disorder (OUD), who was transitioned from daily oral buprenorphine/naloxone therapy.

1. Abstract
Polatuzumab vedotin (Pola) has been approved in China as the first-line treatment in Diffuse Large B-Cell Lymphoma (DLBCL). This study aims to evaluate the efficacy of Pola-based therapy in DLBCL in the real-world, offering insights into treatment patterns and outcomes for newly diagnosed DLBCL in this population.

1. Abstract
Tuberous sclerosis complex (TSC) is a rare genetic disorder characterized by the development of benign tumours in various organs, primarily the kidneys. Renal involvement, often in the form of angiomyolipoma’s (AML).